Trial Profile
A phase II study of PAC-113 for the treatment of Oral-candidiasis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Jul 2016
Price :
$35
*
At a glance
- Drugs PAC 113 (Primary)
- Indications Oral candidiasis
- Focus Therapeutic Use
- 22 Jul 2016 New trial record